Actieve functies van Pieter Oldenziel
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ABLYNX | Directeur/Bestuurslid | 01-01-2019 | - |
Sanofi Foreign Participations BV
 Sanofi Foreign Participations BV Pharmaceuticals: GenericHealth Technology Part of Sanofi, Sanofi Foreign Participations BV is a Dutch company that manufactures human monoclonal antibody drugs. The company is based in Amsterdam, Netherlands. The company was founded in 1998. The CEO is Pieter Oldenziel. | Algemeen Directeur | - | - |
Loopbaan van Pieter Oldenziel
Statistieken
Internationaal
| België | 2 |
| Nederland | 2 |
Operationeel
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
Sanofi Foreign Participations BV
Sanofi Foreign Participations BV Pharmaceuticals: GenericHealth Technology Part of Sanofi, Sanofi Foreign Participations BV is a Dutch company that manufactures human monoclonal antibody drugs. The company is based in Amsterdam, Netherlands. The company was founded in 1998. The CEO is Pieter Oldenziel. | Health Technology |
- Beurs
- Insiders
- Pieter Oldenziel
- Ervaring